More in Industry
‘I wanted to go where I was needed’
Yuliya McAnany, a senior associate scientist at Amicus Therapeutics, talked to our industry careers columnist about her work.
Parents become drug developers to save their children’s lives
Half of all rare-disease patients are children, and their families have long pushed to speed up cures. Now, some families are forming their own biotech businesses.
As pharma loses interest in new antibiotics, infections grow stronger
CDC reports that infections unfazed by oral antibiotics expanded their range during the first year of the COVID-19 pandemic.
‘Our technology allows you to name the nameless’
Swathi A. Kumar is senior director of marketing at Verogen, a company based in San Diego that produces next-generation sequencing solutions for forensic investigations.
Starting a career in data science
Meet Tara Baris of HUB Ocean.
Novavax is angling to win over mRNA defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
What’s it like to work at 23andMe?
More in Industry
‘We're all a bunch of weirdos doing our stuff’
An interview with Charles Sanders, a research associate at XBiotech.
How Robert Langer failed repeatedly but kept going
"They said I should give up, but I don’t like to give up," the pioneer in delivering mRNA to the body said.
'Anywhere you go, be ready to review your work'
Maria Grandoni is a scientist at PPD. She talked to our industry careers columnist about her work on the manufacturing and quality side of industry.
Ole Miss strikes $5M deal with company warned for claiming essential oils can cure COVID
Companies have long sought to partner on research with public universities, which, starved for state funding, eagerly take private dollars.
‘Have faith in that training’
Raghuvir Sengupta has been a biochemist for HP and is now a Pfizer postdoc. He talks about his work and how his graduate training prepared him for his industry career.
90% of drugs fail clinical trials
Here’s one way researchers can select better drug candidates.
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.